⚡️ 3 US Growth Stocks With Insider Ownership As High As 37%

Neutral News

Simply Wall St Growth Rating: ★★★★★☆ Overview: Corcept Therapeutics Incorporated is involved in the discovery and development of drugs for treating severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States, with a market cap of approximately $5.25 billion.

Recent Mentions

CACC

See sentiment for CACC and 5000+ other stocks

News Sentiment

Today

Low Data

Sources

Yahoo

81.25%

SeekingAlpha

18.75%